Skip to main content
Clinical Trials/NCT05723302
NCT05723302
Completed
Not Applicable

The Effect of Resistant Proprioceptive Neuromuscular Facilitation Exercises on Respiratory Muscle Strength in Chronic Obstructive Pulmonary Diseases

Istanbul Medipol University Hospital2 sites in 1 country31 target enrollmentJanuary 20, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Obstructive Pulmonary Disease
Sponsor
Istanbul Medipol University Hospital
Enrollment
31
Locations
2
Primary Endpoint
HADS
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

To investigate the effects of resistant proprioceptive neuromuscular facilitation exercises on physical fitness, respiratory muscle strength, walking distance and quality of life in chronic obstructive pulmonary patients.

Detailed Description

The study was carried out between January 2017 and January 2019, with patients followed up with the diagnosis of COPD in Çanakkale Mehmet Akif Ersoy State Hospital and Çanakkale Onsekiz Mart University Medical Faculty Hospital, Department of Chest Diseases. It was approved by Istanbul Medipol University Non-Interventional Clinical Research Ethics Committee (Date: 30.12.2016, Decision No. 573) and was done in accordance with the Declaration of Helsinki. All participants were informed about the purpose of the study, the total duration of treatment and the applications to be made, and a consent form was signed. The study was conducted as a prospective and randomized controlled study, and inclusion and exclusion criteria were determined. Thirty-five patients diagnosed with COPD were referred to the study, four patients were excluded because they did not meet the inclusion criteria, and the study was conducted with a total of 31 participants. The 31 patients included in the study were randomized after their initial evaluation and divided into two groups as experimental and control groups. Patients meeting the inclusion criteria were divided into 2 groups. Randomized by ordering by date of application.

Registry
clinicaltrials.gov
Start Date
January 20, 2017
End Date
December 1, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Istanbul Medipol University Hospital
Responsible Party
Principal Investigator
Principal Investigator

sevda vurur

Student

Istanbul Medipol University Hospital

Eligibility Criteria

Inclusion Criteria

  • To be diagnosed with stage 1, stage 2 and stage 3 COPD according to GOLD (Global Initiative for Obstructive Lung Diseases) criteria
  • Having FEV1/FVC \<70% according to pulmonary function test
  • Being clinically stable
  • Being over 18 years old
  • Volunteer to participate in the program

Exclusion Criteria

  • Having a COPD exacerbation in the last 8 weeks
  • To have participated in a regular exercise training program in the last 1 year
  • Having a musculoskeletal disease and neuromuscular disease that may prevent exercise
  • Inability to cooperate for pulmonary function test and respiratory muscle strength measurement
  • Being on long-term oxygen therapy

Outcomes

Primary Outcomes

HADS

Time Frame: 10 minutes

Hospital Anxiety Depression Scale

Secondary Outcomes

  • SGRQ(15 minutes)

Study Sites (2)

Loading locations...

Similar Trials